Mylan, the manufacturer of EpiPen, a lifesaving allergy injection, joined the ranks of Martin Shkreli and received a lot of backlash in 2016 over the pen’s multiple price hikes – which left the medication unaffordable for many Americans. That sparked interest in many companies to come up with alternatives to the EpiPen. Mylan has faced competition before, however, they have managed to hold a near monopoly on the market until now. How will the new EpiPen competitors perform? Find out more here. (Source: Carolyn Y. Johnson, The Washington Post, 1/19/17)
You are here: / / Is EpiPen Ready for New Competition?